Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barten

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 16, 2007
Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): a gamma-secretase inhibitor with Abeta lowering activity in a transgenic mouse model of Alzheimer's diseaseC V C Prasad, Ming Zheng, Shikha Vig, et al.
Plos One|August 26, 2014
Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's diseasePaul D Wes, Amy Easton, John Corradi, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2012
2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitorsMichael F Parker, Donna M Barten, Carl P Bergstrom, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Amino-caprolactam derivatives as gamma-secretase inhibitorsMichael F Parker, Joanne J Bronson, Donna M Barten, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE)Kenneth M Boy, Jason M Guernon, Jianliang Shi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2004
Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitorD M Barten, V L Guss, J A Corsa, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2015
Macrocyclic prolinyl acyl guanidines as inhibitors of β-secretase (BACE)Kenneth M Boy, Jason M Guernon, Yong-Jin Wu, et al.
Faraday Discussions|March 5, 2025
Iodine speciation in snow during the MOSAiC expedition and its implications for Arctic iodine emissionsLucy V Brown, Ryan J Pound, Matthew R Jones, et al.
Plos One|May 2, 2015
Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy modelsSethu Sankaranarayanan, Donna M Barten, Laurel Vana, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 25, 2012
Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027Donna M Barten, Patrizia Fanara, Cathy Andorfer, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|May 16, 2007
Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): a gamma-secretase inhibitor with Abeta lowering activity in a transgenic mouse model of Alzheimer's diseaseC V C Prasad, Ming Zheng, Shikha Vig, et al.
Plos One|August 26, 2014
Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's diseasePaul D Wes, Amy Easton, John Corradi, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2012
2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitorsMichael F Parker, Donna M Barten, Carl P Bergstrom, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Amino-caprolactam derivatives as gamma-secretase inhibitorsMichael F Parker, Joanne J Bronson, Donna M Barten, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE)Kenneth M Boy, Jason M Guernon, Jianliang Shi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2004
Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitorD M Barten, V L Guss, J A Corsa, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2015
Macrocyclic prolinyl acyl guanidines as inhibitors of β-secretase (BACE)Kenneth M Boy, Jason M Guernon, Yong-Jin Wu, et al.
Faraday Discussions|March 5, 2025
Iodine speciation in snow during the MOSAiC expedition and its implications for Arctic iodine emissionsLucy V Brown, Ryan J Pound, Matthew R Jones, et al.
Plos One|May 2, 2015
Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy modelsSethu Sankaranarayanan, Donna M Barten, Laurel Vana, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 25, 2012
Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027Donna M Barten, Patrizia Fanara, Cathy Andorfer, et al.
Pageof 10